risks of taking tirzepatide and Cancer Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis The benefits and risks of

If you are keen to know what BMI qualifies for weight loss medication, we will unpack everything you need to know about BMI and weight loss treatment in this guide

Authors Lucas Oliveira, Nutritionist, ProVeg International Anna-Lena Klapp, Head of Research, ProVeg International We would like to thank the following people for sharing their time, expertise, and thoughtful review of the brochure: Valentina Gallani, Health & Nutrition Manager, ProVeg International Veronika Mlynrik Baov, Senior Nutrition Specialist, ProVeg Czech Republic Laura Weinhold, Dietitian & Food Services Specialist, ProVeg Germany Stefany Guerreiro Lima, Food and Nutrition Project Manager, ProVeg Brasil Frequently asked questions What should I eat while on GLP-1 medication

In essence, compounded GLP-1 medications bridge the gap between accessibility and clinical integrity

GLP-1 receptor agonists caused dose-dependent thyroid C-cell tumors in rodent studies

GLP-1 receptor agonists, and related dual GIP/GLP-1 agonists, are injectable or oral medications that mimic hormones involved in blood sugar control and appetite

Compounded products are not FDA-approved and are not interchangeable with brand-name tirzepatide, but the active peptide behaves the same way once injected